Breaking News Instant updates and real-time market news.

ICPT

Intercept

$67.79

0.22 (0.33%)

09:02
10/13/17
10/13
09:02
10/13/17
09:02

Intercept extends partnership with TARGET PharmaSolutions

TARGET PharmaSolutions is pleased to announce that Intercept has extended its strategic partnership for TARGET-NASH to a multi-year agreement.

  • 06

    Nov

ICPT Intercept
$67.79

0.22 (0.33%)

10/02/17
RBCM
10/02/17
NO CHANGE
RBCM
Enanta data positive, says RBC Capital
RBC Capital analyst Brian Abrahams says that preclinical data on Enanta's (ENTA) EDP-305 presented at the AASLD conference "shows comparable-to-better effects on fibrosis to other anti-fibrotic agents." The analyst says that although the test was done on rats, other anti-fibrotic agents' impact on fibrosis in rats has been similar to their impact on fibrosis in humans. The analyst adds that the data indicates that EDP-305 may have a more beneficial effect on cholesterol genes than Intercept's (ICPT) Ocaliva drug. The analyst predicts that Phase I data on Enanta's drug, expected to be presented at the end of the conference, to be positive and potentially cause the shares to rise. He keeps an Outperform rating on Enata.
10/04/17
JMPS
10/04/17
DOWNGRADE
JMPS
Market Perform
Intercept downgraded to Market Perform from Outperform at JMP Securities
10/04/17
10/04/17
DOWNGRADE

Market Perform
Intercept downgraded on reduced NASH expectations at JMP Securities
As previously reported, JMP Securities analyst Liisa Bayko downgraded Intercept to Market Perform from Outperform after she adjusted her assumptions for market penetration of Ocaliva in NASH given the rapidly evolving competitive landscape and cases of serious liver injury and deaths reported in Ocaliva-treated PBC patients. The analyst, who has removed cirrhotic patients from her NASH model to be conservative, now believes Intercept is fairly valued at current levels.
10/06/17
GHSC
10/06/17
INITIATION
Target $136
GHSC
Buy
Intercept initiated with a Buy at Seaport Global
Seaport Global analyst Vernon Bernardino initiated Intercept with a Buy and $136 price target. The analyst expects Q4 prescription trends will support growing confidence that the FDA's statement has not had a longterm effect on Ocaliva Rx behavior in its approved use in patients with primary biliary cholangitis.

TODAY'S FREE FLY STORIES

YOGA

YogaWorks

$2.86

-0.04 (-1.38%)

07:07
10/19/17
10/19
07:07
10/19/17
07:07
Hot Stocks
YogaWorks acquires seven Houston studios »

YogaWorks announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QURE

uniQure

$9.47

-2.2 (-18.85%)

07:07
10/19/17
10/19
07:07
10/19/17
07:07
Hot Stocks
uniQure acquires patent family providing protection of FIX-Padua »

uniQure N.V. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEVA

CEVA

$45.15

-0.25 (-0.55%)

07:07
10/19/17
10/19
07:07
10/19/17
07:07
Hot Stocks
CEVA and Cyberon partner for voice activation solution for smartphones »

CEVA and Cyberon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

RCI

Rogers Communications

$53.75

-0.23 (-0.43%)

07:07
10/19/17
10/19
07:07
10/19/17
07:07
Hot Stocks
Breaking Hot Stocks news story on Rogers Communications »

Rogers Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

SBGI

Sinclair Broadcast

$30.35

0.3 (1.00%)

, TRCO

Tribune Media

07:06
10/19/17
10/19
07:06
10/19/17
07:06
Periodicals
FCC extends comment period for Sinclair-Tribune deal, Reuters reports »

The Federal…

SBGI

Sinclair Broadcast

$30.35

0.3 (1.00%)

TRCO

Tribune Media

DISH

Dish

$49.71

0.86 (1.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 01

    Nov

RCI

Rogers Communications

$53.75

-0.23 (-0.43%)

07:06
10/19/17
10/19
07:06
10/19/17
07:06
Earnings
Rogers Communications backs FY17 revenue growth view 3%-5% 

Consensus $11.34B.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

NAK

Northern Dynasty

$2.09

0.1 (5.03%)

07:06
10/19/17
10/19
07:06
10/19/17
07:06
Initiation
Northern Dynasty initiated  »

Northern Dynasty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESTE

Earthstone Energy

$10.54

-0.15 (-1.40%)

07:05
10/19/17
10/19
07:05
10/19/17
07:05
Syndicate
Earthstone Energy 4.5M share Spot Secondary priced at $9.25 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

  • 16

    May

  • 19

    Oct

RCI

Rogers Communications

$53.75

-0.23 (-0.43%)

07:05
10/19/17
10/19
07:05
10/19/17
07:05
Hot Stocks
Rogers Communications raises FY17 adj operating profit growth view to 5%-6% »

With plans to invest the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

PM

Philip Morris

$112.51

-0.14 (-0.12%)

07:05
10/19/17
10/19
07:05
10/19/17
07:05
Hot Stocks
Philip Morris CEO says Q3 results 'very strong' »

"As expected, our…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

BX

Blackstone

$33.49

0.27 (0.81%)

07:05
10/19/17
10/19
07:05
10/19/17
07:05
Earnings
Blackstone reports Q3 ENI 69c, consensus 54c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 22

    Oct

  • 07

    Nov

ABCB

Ameris Bancorp

$49.45

0.3 (0.61%)

07:04
10/19/17
10/19
07:04
10/19/17
07:04
Earnings
Ameris Bancorp reports Q3 adjusted EPS 63c, consensus 65c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 15

    Nov

  • 28

    Nov

V

Visa

$107.80

0.26 (0.24%)

07:04
10/19/17
10/19
07:04
10/19/17
07:04
Hot Stocks
Visa announces security platform Visa ID Intelligence »

Visa announced Visa ID…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 25

    Oct

  • 29

    Nov

PM

Philip Morris

$112.51

-0.14 (-0.12%)

07:04
10/19/17
10/19
07:04
10/19/17
07:04
Earnings
Philip Morris revises FY17 reported EPS view to $4.75-$4.80, consensus $4.84 »

PMI revises its 2017…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

SPX

S&P 500

07:04
10/19/17
10/19
07:04
10/19/17
07:04
Hot Stocks
Trump thinks Republicans have votes for budget approval »

President Trump just…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCI

Rogers Communications

$53.75

-0.23 (-0.43%)

07:03
10/19/17
10/19
07:03
10/19/17
07:03
Earnings
Rogers Communications reports Q3 EPS C$1.01, consensus C$0.80 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

PM

Philip Morris

$112.51

-0.14 (-0.12%)

07:02
10/19/17
10/19
07:02
10/19/17
07:02
Earnings
Philip Morris reports Q3 adjusted EPS $1.27, consensus $1.38 »

Reports Q3 revenues,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

ERIC

Ericsson

$5.98

0.08 (1.36%)

07:02
10/19/17
10/19
07:02
10/19/17
07:02
Downgrade
Ericsson rating change  »

Ericsson downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRV

Travelers

$130.02

1.37 (1.06%)

07:01
10/19/17
10/19
07:01
10/19/17
07:01
Hot Stocks
Travelers reports Q3 combined ratio of 103.2% »

Including 10.7 points of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 13

    Nov

USO

United States Oil Fund

$10.48

-0.01 (-0.10%)

07:01
10/19/17
10/19
07:01
10/19/17
07:01
Technical Analysis
United States Oil Fund: Pivot points, pivot low edged »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOP

SPDR Oil Exploration and Production Fund

$33.35

-0.32 (-0.95%)

07:00
10/19/17
10/19
07:00
10/19/17
07:00
Technical Analysis
SPDR Oil Exploration and Production Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$26.40

0.3 (1.15%)

06:59
10/19/17
10/19
06:59
10/19/17
06:59
Technical Analysis
VelocityShares 3x Inv Natural Gas ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRV

Travelers

$130.02

1.37 (1.06%)

06:59
10/19/17
10/19
06:59
10/19/17
06:59
Hot Stocks
Breaking Hot Stocks news story on Travelers »

Travelers reports Q3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 13

    Nov

UGAZ

VelocityShares 3x Long Natural Gas ETN

$10.23

-0.17 (-1.63%)

06:58
10/19/17
10/19
06:58
10/19/17
06:58
Technical Analysis
VelocityShares 3x Long Natural Gas ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRV

Travelers

$130.02

1.37 (1.06%)

06:58
10/19/17
10/19
06:58
10/19/17
06:58
Hot Stocks
Travelers reports Q3 book value per share $86.73 »

Reports Q3 adjusted book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.